Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People diagnosed with one of these types of amyloidosis: transthyretin amyloidosis caused by a genetic mutation (hereditary TTR), transthyretin amyloidosis not caused by a mutation (wild-type TTR), or light chain amyloidosis (AL)
- People who are members of a French social security scheme (as a member or a dependent), not including AME (state medical aid)
- People who have given written agreement to take part in the trial
- People who score 3 or higher on at least one symptom (such as breathlessness, digestive problems, nausea, pain, anxiety, or depression) on a standard symptom questionnaire called the EESE-R
- People whose overall score on the EESE-R questionnaire is 10 or higher
Who may not be able to join:
- People who experience a significant drop in blood pressure when standing up (orthostatic hypotension)
- People who have a form of amyloidosis that causes fragile, blistering skin (bullous amyloidosis)
- People who have previously received Shiatsu (a type of pressure-point massage) treatment
- People who are not able to sit upright on their own
- People who are not able to travel independently from home to the hospital
- People who are currently taking part in another interventional research study, or who are still within a required waiting period after a previous study
- People who are known to be pregnant or breastfeeding
- People who are under legal guardianship at the time of joining the trial
- People who are covered under AME (French state medical aid)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 00 33 6 35 37 61 63
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
EESE-R (ESAS) TOTAL SYMPTOM SCORE AT 48 HOURS AFTER THIRD SHIATSU SESSION
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.